Association of 75/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B cell molecule CD20. Evidence against involvement of the cytoplasmic regions of CD20
about
CD20 deficiency in humans results in impaired T cell-independent antibody responsesA cholesterol-dependent CD20 epitope detected by the FMC7 antibodyActivation of the calcium-permeable cation channel CD20 by alpha subunits of the Gi proteinRituximab: mechanisms and applications.CD20-mediated apoptosis: signalling through lipid rafts.Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance.Multimodality imaging of coiled-coil mediated self-assembly in a "drug-free" therapeutic system.Regulation of CD20 in rituximab-resistant cell lines and B-cell non-Hodgkin lymphomaCellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies.Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway.Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions.Molecular mechanisms of resistance to Rituximab and pharmacologic strategies for its circumvention.Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemia.Rituximab: current status as therapy for malignant and benign hematologic disorders.Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia.The MS4A family: counting past 1, 2 and 3.An improved bicistronic CD20/tCD34 vector for efficient purification and in vivo depletion of gene-modified T cells for adoptive immunotherapy.CD20 homo-oligomers physically associate with the B cell antigen receptor. Dissociation upon receptor engagement and recruitment of phosphoproteins and calmodulin-binding proteins.Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis.Rituxan (anti-CD20 antibody)-induced translocation of CD20 into lipid rafts is crucial for calcium influx and apoptosis.Characterization of BIS20x3, a bi-specific antibody activating and retargeting T-cells to CD20-positive B-cellsRapid redistribution of CD20 to a low density detergent-insoluble membrane compartment.Human airway epithelial cells stimulate T-lymphocyte lck and fyn tyrosine kinase.Patterns of expression, membrane localization, and effects of ectopic expression suggest a function for MS4a4B, a CD20 homolog in Th1 T cells.Activation of a calcium-permeable cation channel CD20 expressed in Balb/c 3T3 cells by insulin-like growth factor-I.Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland.Costimulatory signals distinctively affect CD20- and B-cell-antigen-receptor-mediated apoptosis in Burkitt's lymphoma/leukemia cells.
P2860
Q24653638-90E264BA-06F4-4CF3-B243-7079C5B08978Q28183678-71A69A4C-0A0D-4892-A192-762D100E2B60Q28239531-F6984AE6-66A0-4ACD-8BCB-81E06D0284BDQ34462378-5FB591FF-8576-4A1C-A13B-BCB4CA2765F8Q34969960-E43EC787-D3AD-49AA-BD2C-6D39D6698BADQ35567244-4BD6E5F6-5EE3-4E08-ABAB-4B482513BA0DQ35611416-70549213-B737-459C-B436-3289008EC14EQ35783537-4A3655CE-6885-4CE9-8B45-A652DBE035C1Q36079223-F6CD8B34-3574-4B82-B426-8DE5530B1EBBQ36213094-DF742613-2CAD-4873-84F6-02E5F5C5C846Q36398329-5A0A64F1-BA9D-4C3A-9340-69739DA0BC33Q36832106-BF2D185D-3595-4DB1-A17A-C0EEB991143BQ37448352-D5141AD9-E32C-4561-930C-0D7EDC46C752Q37613872-B8B5B17D-635B-433C-A821-C393792758C3Q37984551-3085A574-DFA2-4698-B9F7-B3F6A9A0A05FQ38068932-125377EB-D359-4511-A9C2-EE947038A06EQ38401877-F232B64E-BADA-4931-A448-77E5ECAB809DQ39704843-BD76C46D-F4CA-4AAA-B0EF-4641AB89F00FQ39982968-543ECD7A-B8E6-4753-AD93-38D73D74909BQ40384471-379A94A1-ED04-4A2F-AFE6-C28329EC8749Q40454662-4FF9DDCC-632A-4724-9A46-BC73CBCFC9F9Q40812107-A07CCF7B-8DAB-4C8C-8616-52EB8B6DABDBQ41067716-0647D9AF-B3D4-4858-8205-037C34A7F56BQ41078446-5947403A-0558-4D82-9798-C9FA2FD254BCQ42741822-CE86E641-4762-498D-B368-25A9F42DCB97Q42803613-D1C42C73-0896-4DA9-BF53-BD52B2F1E63BQ52002693-D98D0D28-2D28-4260-8A03-4C35FF8C1625Q52105078-A2D51D33-7D94-4E3B-A09D-87D53ABD3623
P2860
Association of 75/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B cell molecule CD20. Evidence against involvement of the cytoplasmic regions of CD20
description
1995 nî lūn-bûn
@nan
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Association of 75/80-kDa phosp ...... he cytoplasmic regions of CD20
@ast
Association of 75/80-kDa phosp ...... he cytoplasmic regions of CD20
@en
Association of 75/80-kDa phosp ...... he cytoplasmic regions of CD20
@nl
type
label
Association of 75/80-kDa phosp ...... he cytoplasmic regions of CD20
@ast
Association of 75/80-kDa phosp ...... he cytoplasmic regions of CD20
@en
Association of 75/80-kDa phosp ...... he cytoplasmic regions of CD20
@nl
prefLabel
Association of 75/80-kDa phosp ...... he cytoplasmic regions of CD20
@ast
Association of 75/80-kDa phosp ...... he cytoplasmic regions of CD20
@en
Association of 75/80-kDa phosp ...... he cytoplasmic regions of CD20
@nl
P2093
P2860
P921
P356
P1476
Association of 75/80-kDa phosp ...... he cytoplasmic regions of CD20
@en
P2093
P2860
P304
P356
10.1074/JBC.270.38.22632
P407
P577
1995-09-22T00:00:00Z